1. Home
  2. LODE vs NYXH Comparison

LODE vs NYXH Comparison

Compare LODE & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comstock Inc.

LODE

Comstock Inc.

HOLD

Current Price

$1.72

Market Cap

161.9M

Sector

Industrials

ML Signal

HOLD

Logo Nyxoah SA

NYXH

Nyxoah SA

BUY

Current Price

$0.85

Market Cap

137.5M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
LODE
NYXH
Founded
1999
2009
Country
United States
Belgium
Employees
N/A
N/A
Industry
Major Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
161.9M
137.5M
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
LODE
NYXH
Price
$1.72
$0.85
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $4.20
AVG Volume (30 Days)
★ 1.5M
217.2K
Earning Date
11-02-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 63.55
N/A
EPS
N/A
★ N/A
Revenue
★ $1,553,796.00
N/A
Revenue This Year
$303.79
$275.91
Revenue Next Year
$410.04
$93.27
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.70
$0.80
52 Week High
$4.98
$5.92

Technical Indicators

Market Signals
Indicator
LODE
NYXH
Relative Strength Index (RSI) 22.90 23.47
Support Level N/A N/A
Resistance Level $3.32 $1.69
Average True Range (ATR) 0.11 0.05
MACD 0.00 -0.05
Stochastic Oscillator 6.67 5.85

Price Performance

Historical Comparison
LODE
NYXH

About LODE Comstock Inc.

Comstock Inc commercializes technologies that convert underutilized waste and natural resources into clean energy and supporting products, including electrification, metals, and minerals from end-of-life solar panels. Its subsidiary focuses on producing renewable fuels from waste, energy crops, and woody biomass, supported by facilities in Wisconsin, pilot farms, a biorefinery site in Tulsa, and solar panel recycling operations in Nevada. The Company operates through two high-growth segments and a corporate segment, with its activities grouped into Metals, which generates the majority of revenue, Fuels, Mining, Strategic Investments, and Corporate Services.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: